383 related articles for article (PubMed ID: 26451483)
1. Lack of Neuronal IFN-β-IFNAR Causes Lewy Body- and Parkinson's Disease-like Dementia.
Ejlerskov P; Hultberg JG; Wang J; Carlsson R; Ambjørn M; Kuss M; Liu Y; Porcu G; Kolkova K; Friis Rundsten C; Ruscher K; Pakkenberg B; Goldmann T; Loreth D; Prinz M; Rubinsztein DC; Issazadeh-Navikas S
Cell; 2015 Oct; 163(2):324-39. PubMed ID: 26451483
[TBL] [Abstract][Full Text] [Related]
2. Neuronal TNFα, Not α-Syn, Underlies PDD-Like Disease Progression in IFNβ-KO Mice.
Villanueva EB; Tresse E; Liu Y; Duarte JN; Jimenez-Duran G; Ejlerskov P; Kretz O; Loreth D; Goldmann T; Prinz M; Issazadeh-Navikas S
Ann Neurol; 2021 Nov; 90(5):789-807. PubMed ID: 34476836
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of alpha-synuclein in rat substantia nigra results in loss of dopaminergic neurons, phosphorylation of alpha-synuclein and activation of caspase-9: resemblance to pathogenetic changes in Parkinson's disease.
Yamada M; Iwatsubo T; Mizuno Y; Mochizuki H
J Neurochem; 2004 Oct; 91(2):451-61. PubMed ID: 15447678
[TBL] [Abstract][Full Text] [Related]
4. PIAS2-mediated blockade of IFN-β signaling: a basis for sporadic Parkinson disease dementia.
Magalhaes J; Tresse E; Ejlerskov P; Hu E; Liu Y; Marin A; Montalant A; Satriano L; Rundsten CF; Carlsen EMM; Rydbirk R; Sharifi-Zarchi A; Andersen JB; Aznar S; Brudek T; Khodosevich K; Prinz M; Perrier JM; Sharma M; Gasser T; Issazadeh-Navikas S
Mol Psychiatry; 2021 Oct; 26(10):6083-6099. PubMed ID: 34234281
[TBL] [Abstract][Full Text] [Related]
5. Accumulation of beta-synuclein in cortical neurons is associated with autophagy attenuation in the brains of dementia with Lewy body patients.
Evans T; Kok WL; Cowan K; Hefford M; Anichtchik O
Brain Res; 2018 Feb; 1681():1-13. PubMed ID: 29278715
[TBL] [Abstract][Full Text] [Related]
6. S-Nitrosylation of p62 Inhibits Autophagic Flux to Promote α-Synuclein Secretion and Spread in Parkinson's Disease and Lewy Body Dementia.
Oh CK; Dolatabadi N; Cieplak P; Diaz-Meco MT; Moscat J; Nolan JP; Nakamura T; Lipton SA
J Neurosci; 2022 Apr; 42(14):3011-3024. PubMed ID: 35169022
[TBL] [Abstract][Full Text] [Related]
7. Seeding of protein aggregation causes cognitive impairment in rat model of cortical synucleinopathy.
Espa E; Clemensson EKH; Luk KC; Heuer A; Björklund T; Cenci MA
Mov Disord; 2019 Nov; 34(11):1699-1710. PubMed ID: 31449702
[TBL] [Abstract][Full Text] [Related]
8. Synergistic neuroprotection by coffee components eicosanoyl-5-hydroxytryptamide and caffeine in models of Parkinson's disease and DLB.
Yan R; Zhang J; Park HJ; Park ES; Oh S; Zheng H; Junn E; Voronkov M; Stock JB; Mouradian MM
Proc Natl Acad Sci U S A; 2018 Dec; 115(51):E12053-E12062. PubMed ID: 30509990
[TBL] [Abstract][Full Text] [Related]
9. Human amyloid beta and α-synuclein co-expression in neurons impair behavior and recapitulate features for Lewy body dementia in Caenorhabditis elegans.
Huang X; Wang C; Chen L; Zhang T; Leung KL; Wong G
Biochim Biophys Acta Mol Basis Dis; 2021 Oct; 1867(10):166203. PubMed ID: 34146705
[TBL] [Abstract][Full Text] [Related]
10. rAAV2/7 vector-mediated overexpression of alpha-synuclein in mouse substantia nigra induces protein aggregation and progressive dose-dependent neurodegeneration.
Oliveras-Salvá M; Van der Perren A; Casadei N; Stroobants S; Nuber S; D'Hooge R; Van den Haute C; Baekelandt V
Mol Neurodegener; 2013 Nov; 8():44. PubMed ID: 24267638
[TBL] [Abstract][Full Text] [Related]
11. Age-dependent nigral dopaminergic neurodegeneration and α-synuclein accumulation in RGS6-deficient mice.
Luo Z; Ahlers-Dannen KE; Spicer MM; Yang J; Alberico S; Stevens HE; Narayanan NS; Fisher RA
JCI Insight; 2019 May; 5(13):. PubMed ID: 31120439
[TBL] [Abstract][Full Text] [Related]
12. Beclin 1 gene transfer activates autophagy and ameliorates the neurodegenerative pathology in alpha-synuclein models of Parkinson's and Lewy body diseases.
Spencer B; Potkar R; Trejo M; Rockenstein E; Patrick C; Gindi R; Adame A; Wyss-Coray T; Masliah E
J Neurosci; 2009 Oct; 29(43):13578-88. PubMed ID: 19864570
[TBL] [Abstract][Full Text] [Related]
13. Pathological roles of α-synuclein in neurological disorders.
Vekrellis K; Xilouri M; Emmanouilidou E; Rideout HJ; Stefanis L
Lancet Neurol; 2011 Nov; 10(11):1015-25. PubMed ID: 22014436
[TBL] [Abstract][Full Text] [Related]
14. 14-3-3 Proteins Reduce Cell-to-Cell Transfer and Propagation of Pathogenic α-Synuclein.
Wang B; Underwood R; Kamath A; Britain C; McFerrin MB; McLean PJ; Volpicelli-Daley LA; Whitaker RH; Placzek WJ; Becker K; Ma J; Yacoubian TA
J Neurosci; 2018 Sep; 38(38):8211-8232. PubMed ID: 30093536
[TBL] [Abstract][Full Text] [Related]
15. CD8 T cell nigral infiltration precedes synucleinopathy in early stages of Parkinson's disease.
Galiano-Landeira J; Torra A; Vila M; Bové J
Brain; 2020 Dec; 143(12):3717-3733. PubMed ID: 33118032
[TBL] [Abstract][Full Text] [Related]
16. TIGAR inclusion pathology is specific for Lewy body diseases.
López KLR; Simpson JE; Watson LC; Mortiboys H; Hautbergue GM; Bandmann O; Highley JR
Brain Res; 2019 Mar; 1706():218-223. PubMed ID: 30267647
[TBL] [Abstract][Full Text] [Related]
17. Transgenic mice overexpressing tyrosine-to-cysteine mutant human alpha-synuclein: a progressive neurodegenerative model of diffuse Lewy body disease.
Zhou W; Milder JB; Freed CR
J Biol Chem; 2008 Apr; 283(15):9863-70. PubMed ID: 18238775
[TBL] [Abstract][Full Text] [Related]
18. Alterations in mGluR5 expression and signaling in Lewy body disease and in transgenic models of alpha-synucleinopathy--implications for excitotoxicity.
Price DL; Rockenstein E; Ubhi K; Phung V; MacLean-Lewis N; Askay D; Cartier A; Spencer B; Patrick C; Desplats P; Ellisman MH; Masliah E
PLoS One; 2010 Nov; 5(11):e14020. PubMed ID: 21103359
[TBL] [Abstract][Full Text] [Related]
19. Parkinson's disease and alpha synuclein: is Parkinson's disease a prion-like disorder?
Olanow CW; Brundin P
Mov Disord; 2013 Jan; 28(1):31-40. PubMed ID: 23390095
[TBL] [Abstract][Full Text] [Related]
20. Accumulation of oligomer-prone α-synuclein exacerbates synaptic and neuronal degeneration in vivo.
Rockenstein E; Nuber S; Overk CR; Ubhi K; Mante M; Patrick C; Adame A; Trejo-Morales M; Gerez J; Picotti P; Jensen PH; Campioni S; Riek R; Winkler J; Gage FH; Winner B; Masliah E
Brain; 2014 May; 137(Pt 5):1496-513. PubMed ID: 24662516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
